Clinical trials / NCT06851559
NCT06851559Phase 2Active not recruiting

A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks

Study sponsor: Phathom Pharmaceuticals, Inc. · PHAT

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2026-10Estimated
Enrollment · participants95Actual
Source updated2026-06-29Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 4 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

80 participants (planned)

+ After

95 participants (actual)

Primary completion date changed

− Before

Dec 2026

+ After

Oct 2026

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source

· 1 field changed

Recruitment status changed

− Before

Not yet recruiting

+ After

Recruiting

Check registry source